Loading
No insider purchase over the last 90 days. The latest was filed 18 Dec 2023.
Metlife Inc: what insiders have been doing
Every trade that managers of Metlife Inc disclose to SEC (Form 4) is tracked on this page. The company sits in the Banks sector and is based in New York City, United States. It was founded in 1868. From 18 October 2025 to 18 October 2026, the disclosure feed for Metlife Inc logged 88 filings by 25 insiders.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
For context, the typical company on the same exchange (median of 5,458 companies) published 22 filings over the same period, against 88 filings here. The full history, which starts in 2016, counts 2 purchases against 11 sales. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported revenue of 77.08 bn USD and net income of 3.38 bn USD, with a dividend of 2.25 USD per share.
Over the last twelve months, not one insider purchase of Metlife Inc stock was filed. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4.
In the same sector, recent insider purchases at First Guaranty Bancshares, Inc. and BCB Bancorp Inc also feature in our signals. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
567
Thresholds
n/a
Buy Volume
€9,262
2 ops. · all time
Sell Volume
€6M
11 ops. · all time
Who traded when
BuySalePappas Bill1 sale
Analyst consensus: bullish or bearish?
Analysts rate Metlife Inc Buy (bullish), based on 16 analysts. Average price target: US$107.38.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 8,561 of 24,148 companies
58.8
score / 100
Value67
Quality51
FCF yld27%
Earn yld5.3%
EV/EBITDA13.9x
ROE13%
Gross mgn·
Net mgn4.5%
Debt/EBITDA3.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$100.76
Analyst consensus
16 analystsBuy
US$84.00Target US$107.38(+7%)US$119.00
Income statement
RevenueUS$75.7B
EBITDAUS$6B8% margin
Net incomeUS$3.4B4.6% margin
Valuation
PER (trailing)19.3x
PER (forward)9.0x
P/Book2.3x
Beta0.78
Balance sheet & cash
Market capUS$64B
Total debtUS$20.2B
Free Cash FlowUS$17.1B
Debt / Equity180%
Profitability & ownership
ROE13.1%
ROA0.5%
% insiders16.4%
% institutions78.3%
Last declaration on 6 October 2026
Declarations567 total
160 shares@ US$96.880.0000% mcap18.8% of flowCommon StockSEC144:0001628280-26-065234
544 shares@ US$94.350.0001% mcap4.6% of flowCommon StockSEC:0001754648-26-000015:0
544 shares0Common StockSEC:0001785997-26-000010:0
544 shares0Common StockSEC:0001836301-26-000020:0
941 shares@ US$94.350.0001% mcap3.5% of flowCommon StockSEC:0001283051-26-000015:0
544 shares@ US$94.350.0001% mcap7.3% of flowCommon StockSEC:0001707516-26-000015:0
544 shares@ US$94.350.0001% mcap19.1% of flowCommon StockSEC:0002066326-26-000015:0
544 shares@ US$94.350.0001% mcap8.0% of flowCommon StockSEC:0001707351-26-000025:0
544 shares@ US$94.350.0001% mcap10.2% of flowCommon StockSEC:0002013372-26-000016:0
544 shares@ US$94.350.0001% mcap42.0% of flowCommon StockSEC:0001420864-26-000024:0
544 shares@ US$94.350.0001% mcap3.8% of flowCommon StockSEC:0001198236-26-000015:0
266 shares@ US$97.3547.6% of flowCommon StockSEC144:0001628280-26-062719
45 shares@ US$97.3515.0% of flowCommon StockSEC144:0001628280-26-062731
25 shares@ US$97.3559.8% of flowCommon StockSEC144:0001628280-26-062728
224 shares@ US$97.3531.9% of flowCommon StockSEC144:0001628280-26-062735
59 shares@ US$95.500.8% of flowCommon StockSEC:0001707516-26-000013:0
10 shares@ US$95.501.3% of flowCommon StockSEC:0001420864-26-000022:0
618 shares@ US$95.502.3% of flowCommon StockSEC:0001283051-26-000013:0
42 shares@ US$95.500.7% of flowCommon StockSEC:0001707351-26-000020:0
39 shares@ US$95.500.8% of flowCommon StockSEC:0002013372-26-000014:0
294 shares@ US$95.502.1% of flowCommon StockSEC:0001198236-26-000013:0
157 shares@ US$95.501.4% of flowCommon StockSEC:0001754648-26-000013:0
115 shares@ US$95.500.6% of flowCommon StockSEC:0001714199-26-000011:0
21 shares@ US$95.500.9% of flowCommon StockSEC:0002066326-26-000013:0
160 shares@ US$96.2552.0% of flowCommon StockSEC144:0001628280-26-059404
25 of 567 declarations
About Metlife Inc
MetLife Inc. (NYSE: MET) is a major U.S.-listed insurance and financial services group, headquartered in New York at 200 Park Avenue. Founded in 1868, the company has grown into a global franchise with operations in more than 40 markets and leading positions across the United States, Asia, Latin America, Europe, and the Middle East. For investors, MetLife is a large-cap, diversified insurance platform with a strong international footprint and a long operating history in the United States market. ([metlife.com](https://www.metlife.com/about-us/newsroom/2026/january/metlife-recognized-as-industry-leader-on-fortune-worlds-most-admired-companies-2026-List/))
MetLife’s core business spans life insurance, annuities, employee benefits, and asset management. Its operating model is built around several complementary businesses. Group Benefits serves employers with life, disability, dental, vision, accident, and health protection, alongside wellness-related solutions and voluntary benefits. Retirement & Income Solutions (RIS) focuses on institutional retirement offerings such as pension risk transfer, stable value, institutional income annuities, benefits funding, and structured settlements. The company also runs international businesses in Asia, Latin America, and EMEA, giving it exposure to multiple insurance growth markets and reducing reliance on any single geography. ([metlife.com](https://www.metlife.com/work/?utm_source=openai))
Read moreShow less
From a competitive standpoint, MetLife is one of the most recognizable names in global life and health insurance. Its scale, brand strength, long-dated liability expertise, and broad B2B distribution network support a durable competitive position. In January 2026, MetLife was ranked No. 1 in the Insurance: Life and Health industry on Fortune’s World’s Most Admired Companies list for the seventh consecutive year, highlighting its reputation for financial strength, execution, and market leadership. The company also emphasizes deep expertise in institutional annuities and pension de-risking, areas where long-term relationships and balance-sheet credibility matter materially. ([metlife.com](https://www.metlife.com/about-us/newsroom/2026/january/metlife-recognized-as-industry-leader-on-fortune-worlds-most-admired-companies-2026-List/))
Recent developments suggest continued momentum in both growth and capital management. In February 2026, MetLife reported full-year 2025 results showing growth in premiums, fees and other revenues, as well as higher adjusted earnings, while returning substantial capital to shareholders. In 2025, it announced a $10 billion variable annuity risk transfer transaction, underscoring its ability to structure large-scale balance-sheet optimization deals. MetLife also broadened its product set with new employee-focused offerings, including a cancer support benefit and digital protection initiatives tied to mental health and fraud prevention. Overall, the company remains positioned as a diversified, globally relevant insurer with a strong U.S. listed presence on the NYSE. ([metlife.com](https://www.metlife.com/about-us/newsroom/2026/february/metlife-announces-full-year-and-4q-2025-results/?utm_source=openai))
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
